Company News

SDIX (NASDAQ:SDIX), a provider of biotechnology products and services, announced that it has inked a deal with OriGene Technologies to sell the former’s life science business for $16 million. OriGene has agreed to offer employment to majority of SDIX’s employees.

SDIX (NASDAQ:SDIX), a provider of biotechnology products and services, announced that it has inked a deal with OriGene Technologies to sell the former’s life science business for $16 million. OriGene has agreed to offer employment to majority of SDIX’s employees.

As quoted in the press release:

Francis DiNuzzo, SDIX’s President and CEO, commented, “The sale of our Life Science business to OriGene is a natural progression for SDIX. The combination of our core Life Science business and our Advanced GAT technologies with OriGene’s technologies and global operations will result in a broader portfolio of products and services for our customer base and a reach into markets that SDIX would be challenged to achieve as a standalone business.

Click here to read the full SDIX (NASDAQ:SDIX) press release.

MARKETS

Markets
TSX19062.91+345.79
TSXV647.33+15.54
DOW31500.68+823.32
S&P 5003911.74+116.01
NASD11607.62+375.43
ASX6528.40+19.90

COMMODITIES

Commodities
Gold1827.54+0.47
Silver21.15+0.03
Copper3.740.00
Palladium1879.51+6.50
Platinum911.26+4.32
Oil107.06+2.79
Heating Oil4.24+0.02
Natural Gas6.17-0.07

DOWNLOAD FREE REPORTS

×